Ben-Gurion University researchers have developed a dynamic "smart" drug that targets inflammation in a site-specific manner and could enhance the body's natural ability to fight infection and reduce side-effects.
"This development is important because inhibition of inflammation in a non-specific manner reduces the natural ability to fight infections and is a common side effect of anti-inflammatory biologic therapeutics," said one of the researchers Peleg Rider from Ben-Gurion University of the Negev (BGU), Israel.
AdvertisementThe uniqueness of this novel anti-inflammatory molecule, reported in the current issue of Journal of Immunology, can be found in a singular property. When injected, it acts as a non-active drug. However, a localized site with excessive inflammation will activate it, the study said.
Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis. The researchers demonstrated their findings in a mouse model of local inflammation.
"The beauty of this invention lies in the use of a known natural biological code. We mimicked a natural process that occurs during inflammation," Rider said. "Upon resolution of inflammation, the activation of the protein is also reduced and side effects are avoided," he added.
You May Also Like